Phosphatidylserine: Brain Health, Cortisol, and th…

Phosphatidylserine is a phospholipid that makes up roughly 15% of the total lipid content of the brain. Unlike many brain health supplements that work through neurotransmitter modulation or cerebral blood flow, phosphatidylserine (PS) operates at the most fundamental level of neuronal function: the cell membrane itself. Its role in membrane integrity, receptor function, and cellular signaling makes it one of the most mechanistically grounded cognitive supplements available—a distinction recognized in the FDA's qualified health claim for its use in cognitive health.

What Phosphatidylserine Does in the Brain

Cell membranes are not passive barriers—they are dynamic structures that regulate cell signaling, receptor function, ion transport, and cellular communication. Phospholipids like PS are the primary structural components of these membranes, and their composition determines membrane fluidity and the efficiency of embedded proteins.

In neurons specifically, PS is concentrated on the inner leaflet of the plasma membrane and plays several critical roles. It supports the function of neurotransmitter receptors, activates protein kinase C (involved in memory formation and synaptic plasticity), facilitates acetylcholine release, and contributes to the maintenance of sodium/potassium ATPase pumps critical for neuronal electrical signaling. In aged neurons, PS content in membranes declines, contributing to reduced membrane fluidity and impaired signaling efficiency.

PS also plays a role in neuronal apoptosis: when neurons are irreparably damaged, PS flips to the outer membrane leaflet, signaling microglia and macrophages to clear the cell. This "eat me" signal is essential for removing dysfunctional cells—a process whose impairment may contribute to accumulation of damaged neurons in aging brains.

The FDA-Qualified Health Claim

The FDA has issued two qualified health claims for phosphatidylserine. The first states that "consumption of phosphatidylserine may reduce the risk of dementia in the elderly." The second states that "consumption of phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly." These are qualified claims—not full health claims—reflecting that the supporting evidence is suggestive but not definitive. Nevertheless, it represents a meaningful regulatory acknowledgment of the clinical evidence base, distinguishing PS from supplements with no regulatory recognition whatsoever.

The evidence base for these claims includes multiple randomized controlled trials. A series of trials conducted primarily in the 1990s using PS derived from bovine cortex showed consistent improvements in memory, learning, and cognitive function in older adults with age-associated memory impairment. The bovine-derived PS is no longer commercially available due to concerns about bovine spongiform encephalopathy (BSE), but the evidence established the biological proof of concept.

Clinical Trials in Older Adults

Subsequent trials using plant-derived PS (soy lecithin and sunflower lecithin sources) have generally replicated the cognitive benefits, though effect sizes vary. A landmark study by Crook and colleagues followed older adults with memory complaints and found significant improvements on neuropsychological testing after 12 weeks of PS supplementation at 300mg/day. Improvements were most pronounced in tasks involving naming of familiar persons and recall of recently performed tasks—real-world cognitive functions.

A 2010 trial by Richter et al. in older adults with memory complaints found that PS combined with DHA showed greater improvements than either alone—providing evidence for synergy between these two membrane lipid supplements. The combination makes mechanistic sense: DHA determines membrane fluidity, while PS determines membrane composition. Both are required for optimal neuronal membrane function.

Meta-analyses of the available RCTs generally conclude that PS supplementation at 300mg/day produces modest but statistically significant improvements in memory and cognitive performance in older adults with age-associated memory impairment. Effect sizes are moderate and consistent across trials.

Cortisol Blunting: The Sports Application

Beyond cognitive aging, PS has attracted attention in sports and performance contexts for its ability to blunt cortisol responses to exercise stress. Cortisol is a glucocorticoid hormone released in response to physical and psychological stress that, while adaptive acutely, impairs recovery, suppresses anabolic signaling, and contributes to muscle catabolism when chronically elevated.

A 1992 study by Monteleone et al. found that 800mg/day of PS reduced the cortisol and ACTH response to intense cycling exercise by approximately 30%. Subsequent studies using 400–800mg doses have confirmed cortisol-blunting effects during exercise stress, with some showing concomitant improvements in the cortisol-to-testosterone ratio—a biomarker of anabolic/catabolic balance relevant to recovery.

The practical implication is that PS supplementation at 300–400mg around training sessions may modestly reduce excessive cortisol production in overreaching athletes or those under high training stress. It is not a replacement for adequate recovery, but it may attenuate the cortisol spike in hard training blocks.

Soy vs. Sunflower Sources

Early human trials used soy-derived PS, which remains the most extensively studied form. Soy PS has more published clinical trial data supporting its efficacy. Sunflower-derived PS has emerged as the dominant commercial form due to concerns about soy allergenicity and GMO soy. The phosphatidylserine molecule is identical regardless of source—what differs is the fatty acid composition attached to the glycerol backbone. Direct comparative trials between soy and sunflower PS are limited, but the available data and the structural equivalence of the PS molecule suggest both forms are effective.

PS supplements from both sources should be standardized to provide actual PS content—some products labeled "phosphatidylserine complex" contain mostly other phospholipids with minimal PS. Verify that the supplement specifies phosphatidylserine content per serving.

ADHD Evidence and Dosing

Several trials have examined PS for ADHD in children, with mixed but generally positive results. A 2012 trial found that PS combined with omega-3 fatty acids significantly reduced ADHD symptoms and inattention compared to placebo in 200 children. PS appears to work through cholinergic and dopaminergic mechanisms relevant to attention—the same systems targeted by ADHD medications, though through different pathways and with much smaller effect sizes.

Standard dosing is 100–300mg/day for cognitive maintenance and 300–400mg/day for more significant cognitive issues or cortisol management. Split dosing (100–150mg twice daily) may produce more consistent plasma levels than once-daily dosing. PS is fat-soluble and should be taken with a meal containing dietary fat for optimal absorption.

FAQ

Q: How long does phosphatidylserine take to work? Cognitive effects typically develop over 4–12 weeks of consistent supplementation. This is consistent with the time required for membrane phospholipid composition to shift meaningfully—phospholipids turn over slowly compared to neurotransmitters. Acute effects on cortisol are observable within the dosing window of a single session.

Q: Can phosphatidylserine interact with blood thinners? PS can have mild anticoagulant effects at high doses and may interact with anticoagulant medications. People taking warfarin, aspirin, or other blood thinners should consult a physician before using high-dose PS.

Q: Is PS effective for younger people, or mainly for older adults? Most clinical trials are in older adults with memory concerns. In younger healthy adults, the cognitive effects are smaller and less consistent—there is less room for improvement when baseline function is normal. The cortisol-blunting effect for athletes appears relevant across age groups.

Track your supplements in Optimize.

Phosphatidylserine: Brain Health, Cortisol, and the Evidence